Agomelatine or placebo as adjunctive therapy to a mood stabiliser in bipolar I depression: Randomised double-blind placebo-controlled trial

Lakshmi N. Yatham; Eduard Vieta; Guy M. Goodwin; Michel Bourin; Christian de Bodinat; Judith Laredo; Joseph R. Calabrese

doi:10.1192/bjp.bp.114.147587

Back

Agomelatine or placebo as adjunctive therapy to a mood stabiliser in bipolar I depression: Randomised double-blind placebo-controlled trial

Article 2015 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2006

A Double-Blind, Randomized, Placebo-Controlled, Prophylaxis Study of Adjunctive Gabapentin for Bipolar Disorder

Eduard Vieta, José Manuel Goikolea, Anabel Martínez‐Arán, Mercé Comes, K. Verger, Xavier Masramón, José Sánchez‐Moreno, Francesc Colom

Article2008

A double-blind, randomized, placebo-controlled prophylaxis trial of oxcarbazepine as adjunctive treatment to lithium in the long-term treatment of bipolar I and II disorder

Eduard Vieta, Núria Cruz, Javier García‐Campayo, Rosario de Arce, José Manuel Crespo, Vicenç Vallès, Josefina Pérez‐Blanco, Ernesto Roca, J.M. Olivares, Ángel Moríñigo, Raul Fernández-Villamor, Mercé Comes

Article2009

A 6-month, Randomized, Placebo-controlled, Double Blind Trial of Ziprasidone Plus a Mood Stabilizer in Subjects With Bipolar I Disorder

Eduard Vieta, Charles L. Bowden, Kathleen Ice, Oksana Gurtovaya, Jeffrey H. Schwartz, P. Wang

Article2020

Evaluation of cariprazine in the treatment of bipolar I and II depression: a randomized, double-blind, placebo-controlled, phase 2 trial

Lakshmi N. Yatham, Eduard Vieta, Willie Earley

Article2008

Quetiapine for the treatment of bipolar II depression: Analysis of data from two randomized, double-blind, placebo-controlled studies

Trisha Suppes, Robert M. A. Hirschfeld, Eduard Vieta, Shane Raines, Björn Paulsson

Agomelatine or placebo as adjunctive therapy to a mood stabiliser in bipolar I depression: Randomised double-blind placebo-controlled trial

Abstract

Discussion(0)

Related publications

A Double-Blind, Randomized, Placebo-Controlled, Prophylaxis Study of Adjunctive Gabapentin for Bipolar Disorder

A double-blind, randomized, placebo-controlled prophylaxis trial of oxcarbazepine as adjunctive treatment to lithium in the long-term treatment of bipolar I and II disorder

A 6-month, Randomized, Placebo-controlled, Double Blind Trial of Ziprasidone Plus a Mood Stabilizer in Subjects With Bipolar I Disorder

Evaluation of cariprazine in the treatment of bipolar I and II depression: a randomized, double-blind, placebo-controlled, phase 2 trial

Quetiapine for the treatment of bipolar II depression: Analysis of data from two randomized, double-blind, placebo-controlled studies